Foundry Gross Profitability Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1NVDA | NVIDIA CORP | Technology | $4.91T | 59.87% |
2WMT | WALMART INC | Consumer Defensive | $909.13B | 11.09% |
3MA | MASTERCARD INC | Financial Services | $480.32B | 5.86% |
4APP | APPLOVIN CORP | Technology | $142.62B | 1.74% |
5BKNG | BOOKING HOLDINGS INC | Industrials | $140.78B | 1.72% |
6SBUX | STARBUCKS CORP | Consumer Cyclical | $120.23B | 1.47% |
7ADBE | ADOBE INC | Technology | $94.31B | 1.15% |
8CL | COLGATE PALMOLIVE CO | Consumer Defensive | $74.40B | 0.91% |
9GWW | WW GRAINGER INC | Industrials | $65.86B | 0.80% |
10FAST | FASTENAL CO | Industrials | $52.20B | 0.64% |
11ODFL | OLD DOMINION FREIGHT LINE INC | Industrials | $48.63B | 0.59% |
12IDXX | IDEXX LABORATORIES INC | Healthcare | $44.76B | 0.55% |
13NTRA | NATERA INC | Healthcare | $38.87B | 0.47% |
14KR | KROGER CO | Consumer Defensive | $36.04B | 0.44% |
15ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $35.71B | 0.44% |
16RDDT | REDDIT INC | Communication Services | $34.88B | 0.43% |
17UI | UBIQUITI INC | Technology | $33.04B | 0.40% |
18FICO | FAIR ISAAC CORP | Technology | $29.15B | 0.36% |
19TPR | TAPESTRY INC | Consumer Cyclical | $28.58B | 0.35% |
20JBHT | HUNT J B TRANSPORT SERVICES INC | Industrials | $27.48B | 0.34% |
21WSM | WILLIAMS SONOMA INC | Consumer Cyclical | $26.89B | 0.33% |
22MTD | METTLER TOLEDO INTERNATIONAL INC | Healthcare | $26.47B | 0.32% |
23VRSN | VERISIGN INC | Technology | $25.27B | 0.31% |
24XPO | XPO INC | Industrials | $25.25B | 0.31% |
25EXPD | EXPEDITORS INTERNATIONAL OF WASHINGTON INC | Industrials | $23.91B | 0.29% |
26TEAM | ATLASSIAN CORP | Technology | $23.67B | 0.29% |
27LUV | SOUTHWEST AIRLINES CO | Industrials | $23.50B | 0.29% |
28INCY | INCYTE CORP | Healthcare | $23.42B | 0.29% |
29RL | RALPH LAUREN CORP | Consumer Cyclical | $22.64B | 0.28% |
30SN | SHARKNINJA INC | Consumer Cyclical | $21.87B | 0.27% |
31ROL | ROLLINS INC | Consumer Cyclical | $21.72B | 0.26% |
32ULTA | ULTA BEAUTY INC | Consumer Cyclical | $20.62B | 0.25% |
33BBY | BEST BUY CO INC | Consumer Cyclical | $18.00B | 0.22% |
34NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.18B | 0.21% |
35THC | TENET HEALTHCARE CORP | Healthcare | $16.79B | 0.20% |
36NTNX | NUTANIX INC | Technology | $14.89B | 0.18% |
37DECK | DECKERS OUTDOOR CORP | Consumer Cyclical | $14.79B | 0.18% |
38EXEL | EXELIXIS INC | Healthcare | $14.06B | 0.17% |
39PINS | PINTEREST INC | Communication Services | $13.00B | 0.16% |
40MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $12.76B | 0.16% |
41LULU | LULULEMON ATHLETICA INC | Consumer Cyclical | $12.61B | 0.15% |
42COKE | COCA-COLA CONSOLIDATED INC | Consumer Defensive | $12.03B | 0.15% |
43AXSM | AXSOME THERAPEUTICS INC | Healthcare | $11.84B | 0.14% |
44W | WAYFAIR INC | Consumer Cyclical | $11.79B | 0.14% |
45SAIA | SAIA INC | Industrials | $11.65B | 0.14% |
46HUBS | HUBSPOT INC | Technology | $11.49B | 0.14% |
47PODD | INSULET CORP | Healthcare | $11.36B | 0.14% |
48CART | INSTACART (MAPLEBEAR INC) | Consumer Cyclical | $10.77B | 0.13% |
49DPZ | DOMINOS PIZZA INC | Consumer Cyclical | $10.72B | 0.13% |
50DOCU | DOCUSIGN INC | Technology | $10.07B | 0.12% |
51CORT | CORCEPT THERAPEUTICS INC | Healthcare | $9.72B | 0.12% |
52MANH | MANHATTAN ASSOCIATES INC | Technology | $9.66B | 0.12% |
53LEVI | LEVI STRAUSS & CO | Consumer Cyclical | $9.38B | 0.11% |
54DDS | DILLARD'S INC | Consumer Cyclical | $8.61B | 0.10% |
55CHWY | CHEWY INC | Consumer Cyclical | $8.57B | 0.10% |
56ETSY | ETSY INC | Consumer Cyclical | $7.98B | 0.10% |
57HIMS | HIMS & HERS HEALTH INC | Consumer Defensive | $7.60B | 0.09% |
58RSI | RUSH STREET INTERACTIVE INC | Consumer Cyclical | $7.56B | 0.09% |
59ACI | ALBERTSONS COMPANIES INC | Consumer Defensive | $7.47B | 0.09% |
60DBX | DROPBOX INC | Technology | $7.14B | 0.09% |
61SFM | SPROUTS FARMERS MARKET INC | Consumer Defensive | $7.13B | 0.09% |
62LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.09% |
63MSM | MSC INDUSTRIAL DIRECT CO INC | Industrials | $6.97B | 0.08% |
64HNGE | HINGE HEALTH INC | Healthcare | $6.74B | 0.08% |
65APPF | APPFOLIO INC | Technology | $6.36B | 0.08% |
66SEZL | SEZZLE INC | Financial Services | $5.87B | 0.07% |
67PEGA | PEGASYSTEMS INC | Technology | $5.39B | 0.07% |
68KVYO | KLAVIYO INC | Technology | $5.29B | 0.06% |
69TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $5.27B | 0.06% |
70RELY | REMITLY GLOBAL INC | Technology | $5.08B | 0.06% |
71PTRN | PATTERN GROUP INC | Consumer Cyclical | $4.97B | 0.06% |
72KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $4.92B | 0.06% |
73ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $4.38B | 0.05% |
74RHI | ROBERT HALF INC | Industrials | $4.28B | 0.05% |
75ANF | ABERCROMBIE & FITCH CO | Consumer Cyclical | $4.23B | 0.05% |
76BOX | BOX INC | Technology | $4.22B | 0.05% |
77BBWI | BATH & BODY WORKS INC | Consumer Cyclical | $4.21B | 0.05% |
78KFY | KORN FERRY | Industrials | $4.00B | 0.05% |
79EXTR | EXTREME NETWORKS INC | Technology | $3.97B | 0.05% |
80IPAR | INTERPARFUMS INC | Consumer Defensive | $3.95B | 0.05% |
81WING | WINGSTOP INC | Consumer Cyclical | $3.88B | 0.05% |
82YETI | YETI HOLDINGS INC | Consumer Cyclical | $3.87B | 0.05% |
83LOPE | GRAND CANYON EDUCATION INC | Consumer Defensive | $3.72B | 0.05% |
84NHC | NATIONAL HEALTHCARE CORP | Healthcare | $3.56B | 0.04% |
85ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.56B | 0.04% |
86RNG | RINGCENTRAL INC | Technology | $3.46B | 0.04% |
87WDFC | WD 40 CO | Basic Materials | $3.31B | 0.04% |
88COLM | COLUMBIA SPORTSWEAR CO | Consumer Cyclical | $3.25B | 0.04% |
89WRBY | WARBY PARKER INC | Healthcare | $3.24B | 0.04% |
90CARG | CARGURUS INC | Consumer Cyclical | $3.16B | 0.04% |
91GRND | GRINDR INC | Technology | $2.71B | 0.03% |
92TARS | TARSUS PHARMACEUTICALS INC | Healthcare | $2.58B | 0.03% |
93GRDN | GUARDIAN PHARMACY SERVICES INC | Healthcare | $2.57B | 0.03% |
94PTON | PELOTON INTERACTIVE INC | Consumer Cyclical | $2.55B | 0.03% |
95CALX | CALIX INC | Technology | $2.50B | 0.03% |
96CMPR | CIMPRESS PLC | Communication Services | $2.49B | 0.03% |
97BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.03% |
98BKE | BUCKLE INC | Consumer Cyclical | $2.19B | 0.03% |
99AXGN | AXOGEN INC | Healthcare | $2.12B | 0.03% |
100CDNA | CAREDX INC | Healthcare | $2.05B | 0.03% |
101WMK | WEIS MARKETS INC | Consumer Defensive | $1.93B | 0.02% |
102APPN | APPIAN CORP | Technology | $1.92B | 0.02% |
103CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $1.89B | 0.02% |
104SAM | BOSTON BEER CO INC | Consumer Defensive | $1.86B | 0.02% |
105NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.02% |
106SONO | SONOS INC | Technology | $1.80B | 0.02% |
107FLO | FLOWERS FOODS INC | Consumer Defensive | $1.80B | 0.02% |
108RVLV | REVOLVE GROUP INC | Consumer Cyclical | $1.78B | 0.02% |
109ASAN | ASANA INC | Technology | $1.77B | 0.02% |
110ATRC | ATRICURE INC | Healthcare | $1.77B | 0.02% |
111FIGS | FIGS INC | Consumer Cyclical | $1.72B | 0.02% |
112TDOC | TELADOC HEALTH INC | Healthcare | $1.70B | 0.02% |
113TRIP | TRIPADVISOR INC | Industrials | $1.70B | 0.02% |
114ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.02% |
115IDT | IDT CORP | Communication Services | $1.57B | 0.02% |
116XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | $1.52B | 0.02% |
117INSP | INSPIRE MEDICAL SYSTEMS INC | Healthcare | $1.46B | 0.02% |
118ARLO | ARLO TECHNOLOGIES INC | Basic Materials | $1.45B | 0.02% |
119YELP | YELP INC | Communication Services | $1.44B | 0.02% |
120SBH | SALLY BEAUTY HOLDINGS INC | Consumer Cyclical | $1.42B | 0.02% |
121BJRI | BJS RESTAURANTS INC | Consumer Cyclical | $1.42B | 0.02% |
122BRBR | BELLRING BRANDS INC | Consumer Defensive | $1.41B | 0.02% |
123OMDA | OMADA HEALTH INC | Healthcare | $1.41B | 0.02% |
124WINA | WINMARK CORP | Consumer Cyclical | $1.39B | 0.02% |
125LINC | LINCOLN EDUCATIONAL SERVICES CORP | Consumer Defensive | $1.36B | 0.02% |
126REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.02% |
127LZ | LEGALZOOMCOM INC | Industrials | $1.33B | 0.02% |
128GIC | GLOBAL INDUSTRIAL CO | Industrials | $1.32B | 0.02% |
129ATEC | ALPHATEC HOLDINGS INC | Healthcare | $1.31B | 0.02% |
130UPBD | UPBOUND GROUP INC | Technology | $1.29B | 0.02% |
131ARDX | ARDELYX INC | Healthcare | $1.28B | 0.02% |
132AMPL | AMPLITUDE INC | Technology | $1.27B | 0.02% |
133HLF | HERBALIFE LTD | Consumer Defensive | $1.24B | 0.02% |
134CBRL | CRACKER BARREL OLD COUNTRY STORE INC | Consumer Cyclical | $1.20B | 0.01% |
135PXED | PHOENIX EDUCATION PARTNERS INC | Consumer Defensive | $1.09B | 0.01% |
136GRPN | GROUPON INC | Communication Services | $1.06B | 0.01% |
137KFRC | KFORCE INC | Industrials | $1.04B | 0.01% |
138APEI | AMERICAN PUBLIC EDUCATION INC | Consumer Defensive | $930M | 0.01% |
139EVER | EVERQUOTE INC | Communication Services | $925M | 0.01% |
140RDVT | RED VIOLET INC | Technology | $920M | 0.01% |
141TALK | TALKSPACE INC | Healthcare | $873M | 0.01% |
142TDUP | THREDUP INC | Consumer Cyclical | $852M | 0.01% |
143SIBN | SI-BONE INC | Healthcare | $771M | 0.01% |
144KRT | KARAT PACKAGING INC | Consumer Cyclical | $760M | 0.01% |
145DSP | VIANT TECHNOLOGY INC | Technology | $754M | 0.01% |
146MNTN | MNTN INC | Technology | $661M | 0.01% |
147VLGEA | VILLAGE SUPER MARKET INC | Consumer Defensive | $659M | 0.01% |
148TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $648M | 0.01% |
149NRDS | NERDWALLET INC | Communication Services | $609M | 0.01% |
150OXM | OXFORD INDUSTRIES INC | Consumer Cyclical | $604M | 0.01% |
151GYRE | GYRE THERAPEUTICS INC | Healthcare | $587M | 0.01% |
152MYGN | MYRIAD GENETICS INC | Healthcare | $584M | 0.01% |
153WEAV | WEAVE COMMUNICATIONS INC | Healthcare | $575M | 0.01% |
154OOMA | OOMA INC | Communication Services | $568M | 0.01% |
155ANGO | ANGIODYNAMICS INC | Healthcare | $558M | 0.01% |
156NPCE | NEUROPACE INC | Healthcare | $548M | 0.01% |
157YEXT | YEXT INC | Technology | $535M | 0.01% |
158CTRN | CITI TRENDS INC | Consumer Cyclical | $535M | 0.01% |
159SPT | SPROUT SOCIAL INC | Technology | $518M | 0.01% |
160NRC | NRC HEALTH | Healthcare | $491M | 0.01% |
161IBEX | IBEX LTD | Technology | $474M | 0.01% |
162OFIX | ORTHOFIX MEDICAL INC | Healthcare | $468M | 0.01% |
163VMD | VIEMED HEALTHCARE INC | Healthcare | $466M | 0.01% |
164DCTH | DELCATH SYSTEMS INC | Healthcare | $442M | 0.01% |
165PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $434M | 0.01% |
166BBW | BUILD-A-BEAR WORKSHOP INC | Consumer Cyclical | $428M | 0.01% |
167QMCO | QUANTUM CORP | Technology | $419M | 0.01% |
168HVT | HAVERTY FURNITURE COMPANIES INC | Consumer Cyclical | $413M | 0.01% |
169GCO | GENESCO INC | Consumer Cyclical | $411M | 0.01% |
170USNA | USANA HEALTH SCIENCES INC | Consumer Defensive | $403M | 0.00% |
171NATH | NATHANS FAMOUS INC | Consumer Cyclical | $393M | 0.00% |
172EOLS | EVOLUS INC | Healthcare | $377M | 0.00% |
173BBBY | BED BATH & BEYOND INC | Consumer Cyclical | $372M | 0.00% |
174FENC | FENNEC PHARMACEUTICALS INC | Healthcare | $365M | 0.00% |
175NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $359M | 0.00% |
176LE | LANDS' END INC | Consumer Cyclical | $357M | 0.00% |
177ELMD | ELECTROMED INC | Healthcare | $349M | 0.00% |
178XPOF | XPONENTIAL FITNESS INC | Consumer Cyclical | $328M | 0.00% |
179BKKT | BAKKT INC | Technology | $323M | 0.00% |
180MKTW | MARKETWISE INC | Technology | $314M | 0.00% |
181BKTI | BK TECHNOLOGIES CORP | Technology | $307M | 0.00% |
182DBI | DESIGNER BRANDS INC | Consumer Cyclical | $290M | 0.00% |
183SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.00% |
184LOVE | LOVESAC CO | Consumer Cyclical | $267M | 0.00% |
185QTTB | Q32 BIO INC | Healthcare | $255M | 0.00% |
186NUS | NU SKIN ENTERPRISES INC | Consumer Defensive | $254M | 0.00% |
187JILL | JJILL INC | Consumer Cyclical | $248M | 0.00% |
188SMTI | SANARA MEDTECH INC | Healthcare | $229M | 0.00% |
189FC | FRANKLIN COVEY CO | Industrials | $229M | 0.00% |
190KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.00% |
191AGEN | AGENUS INC | Healthcare | $209M | 0.00% |
192BDSX | BIODESIX INC | Healthcare | $204M | 0.00% |
193RCMT | RCM TECHNOLOGIES INC | Industrials | $196M | 0.00% |
194INFU | INFUSYSTEM HOLDINGS INC | Healthcare | $180M | 0.00% |
195MRDN | MERIDIAN HOLDINGS INC | Communication Services | $171M | 0.00% |
196OWLT | OWLET INC | Healthcare | $162M | 0.00% |
197RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.00% |
198CUE | CUE BIOPHARMA INC | Healthcare | $126M | 0.00% |
199INSG | INSEEGO CORP | Technology | $122M | 0.00% |
200AKA | AKA BRANDS HOLDING CORP | Consumer Cyclical | $119M | 0.00% |
201MED | MEDIFAST INC | Consumer Cyclical | $114M | 0.00% |
202TZOO | TRAVELZOO | Communication Services | $113M | 0.00% |
203VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.00% |
204CSBR | CHAMPIONS ONCOLOGY INC | Healthcare | $85M | 0.00% |
205VNCE | VINCE HOLDING CORP | Consumer Cyclical | $83M | 0.00% |
206AEYE | AUDIOEYE INC | Technology | $82M | 0.00% |
207BARK | BARK INC | Consumer Cyclical | $82M | 0.00% |
208LFVN | LIFEVANTAGE CORP | Consumer Defensive | $78M | 0.00% |
209ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $76M | 0.00% |
210BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.00% |
211BGSF | BGSF INC | Industrials | $65M | 0.00% |
212WFCF | WHERE FOOD COMES FROM INC | Technology | $63M | 0.00% |
213SNWV | SANUWAVE HEALTH INC | Healthcare | $55M | 0.00% |
214ACFN | ACORN ENERGY INC | Technology | $51M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $8.20T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 92% toward Growth. +1% unclassified (19 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 214 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
Required>= 75.0%Actual38.2%Margin-36.8%No more than 25% of total assets may be invested in the securities of any one issuer.
Required<= 25.0%Actual59.9%Margin-34.9%The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual60.3%Margin-35.3%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
At least 50% of total assets must sit in cash, government securities, other RICs, and other securities limited to 5% of assets and 10% of the issuer's voting securities per issuer.
Required>= 50.0%Actual38.2%Margin-11.8%Arithmetically entailed by '40 Act 5(b)(1) diversification (75%/5% asset leg) — it cannot fail independently, so it is reported outside the tally rather than counted as a separate check.
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 214 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 11.9% | -13.6% |
| 3 yearsp.a. | 29.3% | 15.5% |
| 5 yearsp.a. | 14.0% | 11.2% |
| 10 yearsp.a. | 16.8% | 12.3% |
| Since inceptionp.a. | 11.8% | 10.0% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 4.5% | -6.2% |
| 2025 | 23.8% | -2.7% |
| 2024 | 60.2% | 59.6% |
| 2023 | 20.8% | -3.7% |
| 2022 | -27.1% | 9.3% |
| 2021 | 18.0% | 28.5% |
| 2020 | 40.2% | -2.1% |
| 2019 | 30.9% | 6.3% |
| 2018 | -0.4% | 38.7% |
| 2017 | 22.5% | 16.1% |
| 2016 | 1.7% | -5.2% |
| 2015 | 4.7% | 13.0% |
| 2014 | 15.2% | 7.6% |
| 2013 | 36.9% | 5.3% |
| 2012 | 10.8% | -0.1% |
| 2011 | 11.5% | 5.4% |
| 2010 | 20.6% | 2.1% |
| 2009 | 37.2% | 10.5% |
| 2008 | -33.9% | 12.5% |
| 2007 | -5.5% | -17.0% |
| 2006 | 7.2% | -8.4% |
| 2005 | 3.0% | -2.4% |
| 2004 | 21.3% | 5.5% |
| 2003 | 36.7% | 5.5% |
| 2002 | -13.1% | 57.0% |
| 2001 | -17.6% | 34.2% |
| 2000 | 20.6% | 88.4% |
| 1999 | 32.5% | -20.7% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Gross Profitability Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Gross Profitability signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.